Technology Profiles
 Profile Detail
Investment and R&D opportunities in drug development (10 GB 47P8 3I6L)
SME based in the North East of England in the field of early stage drug development is in the process of building a portfolio of IP in the emerging field of pharmaceutical cocrystals, both in terms of product and manufacturing process IP, for subsequent licensing to the pharmaceutical industry. They are looking for potential partners both Financial and R&D for future development.
Country: United Kingdom
Type: OFFER
Date: 12.01.2011
The company is an early stage technology business in the field of drug development. They are in the process of building a portfolio of IP in the emerging field of pharmaceutical cocrystals, both in terms of product and manufacturing process IP, for subsequent licensing to the pharmaceutical industry. The company is conducting research into cocrystal discovery and optimisation but crucially is also developing scalable processes for both the production and nanoisation of drug cocrystals currently an unmet need within industry.
The company was formed in October 2008. The company is developing products and processes in the immediate market opportunity arising from the convergence of advances in crystal engineering, continuous processing and nanoparticulates sciences.
The company has raised limited private capital to begin several small development programmes and support client / customer work and has also been awarded a small development grant to complete initial cocrystal development, characterization and new IP filing.
The company has several ongoing development projects with a range of client and customers from across the pharmaceutical and processing industries but is looking to increase its business to business activities and is looking to engage with companies interested in investment opportunities.
Innovative Aspects:
The main advantages the company are looking to convey to its customers in this sector are:
- Modification of current drug forms into more usable compounds such as modification of their solubility and efficacy
- Possible reduction in the time and cost of drug approval process
- Recover costs and value already sunk' by the pharmaceutical industry into compounds that might presently be regarded as orphans'
- Extension of market and protection for /block-buster compounds from the generic manufacturers, possible patent and product extension
Degree of development:
Patents/Rights: Secret know-how
Requested Cooperation: License Agreement, Joint further development, Financial Resources
- Type of partner sought: Established companies in the pharmaceutical sector looking to further develop or exploit new technologies, or organisations looking to finance R&D development
- Specific area of activity of the partner: several opportunities exist a) to licence the developing technologies b) to collaborate on further R&D c) to co-fund future developments
- Task to be performed by the partner sought: this is open to discussion as many opportunities exist
Type of Organisation:
Status: NEW
| 
